Search alternatives:
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
set decrease » we decrease (Expand Search), sizes decrease (Expand Search), use decreased (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
set decrease » we decrease (Expand Search), sizes decrease (Expand Search), use decreased (Expand Search)
-
161
-
162
-
163
-
164
Outline of study participants.
Published 2025“…</p><p>Methods</p><p>In this secondary analysis, we included elective adult participants (n = 5948) from the third and fourth survey of the Tehran Lipid and Glucose Study. …”
-
165
-
166
The implementation process for the LCG.
Published 2025“…Two safety analyses will be performed at one-third and two-thirds of the way through the trial.…”
-
167
Primary and secondary/exploratory outcomes.
Published 2025“…Two safety analyses will be performed at one-third and two-thirds of the way through the trial.…”
-
168
-
169
-
170
Itemized cost-per-sample breakdown of TMS.
Published 2025“…We captured a high percentage (mean = 77.1%) of targeted CpG sites and produced methylation level estimates that agreed with those generated from reduced representation bisulfite sequencing (R<sup>2</sup> = 0.98). …”
-
171
Adverse event list.
Published 2025“…</p><p>Non-motor symptoms of PD, motor parkinsonian signs off medication, and quality of life improved significantly during the treatment phase, including the MDS-UPDRS total score (mean decrease −11.09; 95% Confidence Interval [CI]; −18, −4.1; <i>p</i> = 0.006), the Parkinson’s disease Questionnaire-39 (PDQ-39) summary index (mean decrease −2.91; 95% CI; −4.4, −1.4; <i>p</i> = 0.005), and the Non-Motor Symptoms Questionnaire (NMS-Quest) (mean decrease −4.27; 95% CI; −6.5, −2.1; <i>p</i> = 0.009). …”
-
172
Patient characteristics.
Published 2025“…</p><p>Non-motor symptoms of PD, motor parkinsonian signs off medication, and quality of life improved significantly during the treatment phase, including the MDS-UPDRS total score (mean decrease −11.09; 95% Confidence Interval [CI]; −18, −4.1; <i>p</i> = 0.006), the Parkinson’s disease Questionnaire-39 (PDQ-39) summary index (mean decrease −2.91; 95% CI; −4.4, −1.4; <i>p</i> = 0.005), and the Non-Motor Symptoms Questionnaire (NMS-Quest) (mean decrease −4.27; 95% CI; −6.5, −2.1; <i>p</i> = 0.009). …”
-
173
-
174
-
175
-
176
-
177
Summary of correlations in previous studies.
Published 2025“…</p><p>Results</p><p>From the third week to the twenty-fourth week of 2023, the weekly median concentration of SARS-CoV-2 RNA fluctuated, starting at 16.94 copies/ml in the third week, decreasing to 1.62 copies/ml by the fifteenth week, then gradually rising to a peak of 41.27 copies/ml in the twentieth week, before ultimately declining to 8.74 copies/ml by the twenty-fourth week. …”
-
178
The characteristics of nine WWTPs.
Published 2025“…</p><p>Results</p><p>From the third week to the twenty-fourth week of 2023, the weekly median concentration of SARS-CoV-2 RNA fluctuated, starting at 16.94 copies/ml in the third week, decreasing to 1.62 copies/ml by the fifteenth week, then gradually rising to a peak of 41.27 copies/ml in the twentieth week, before ultimately declining to 8.74 copies/ml by the twenty-fourth week. …”
-
179
Data Sheet 1_Application oriented material characterisation and simulation for adsorption thermal energy storage.pdf
Published 2025“…The results indicate that the desorption conditions are a better match for CWK NaYBFK while the adsorption conditions are a better match for CWK 13XBFK. In the third step, the experimental breakthrough curves serve to validate a fixed bed simulation that can be used to construct a sorption system for the investigated adsorption and desorption conditions. …”
-
180
Table 1_A multi-strain human skin microbiome model provides a testbed for disease modeling.xlsx
Published 2025“…Skin cells formed a complex tissue structure over two weeks and maintained stable or increasing TEER after 7 days of co-culture with the microbial consortium. …”